While it is reasonable that therapy on an area where cancer is believed to exist may improve outcomes (and for other cancers, this has been done, so selected women with breast cancer get equivalent
outcomes without needing to remove the entire breast), the actual available
data involves largely case series of patients who were never compared with other therapeutic options (hence the data is for frank cancer, not an atypical biopsy). Hence, the merit of the procedure is not really known.